Published in J Assoc Nurses AIDS Care on March 24, 2017
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS (2007) 3.58
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (2012) 3.46
Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health (2003) 3.22
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS (2005) 2.91
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr (2004) 2.90
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS (2007) 2.52
High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend (2002) 2.04
Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev (2003) 2.03
Evaluating respondent-driven sampling in a major metropolitan area: Comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studies. Ann Epidemiol (2010) 1.97
Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr (2003) 1.89
Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana. Am J Drug Alcohol Abuse (2014) 1.75
Reducing drug use, human immunodeficiency virus risk, and recidivism among young men leaving jail: evaluation of the REAL MEN re-entry program. J Adolesc Health (2010) 1.70
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr (2005) 1.69
Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health (2005) 1.67
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health (2013) 1.65
Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review. Addiction (2013) 1.64
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62
Symptoms of posttraumatic stress disorder in a New Orleans workforce following Hurricane Katrina. J Urban Health (2007) 1.61
Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction (2012) 1.55
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health (2003) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.50
Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia. Int J STD AIDS (2002) 1.50
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health (2004) 1.49
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health (2009) 1.49
Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat (2003) 1.41
Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend (2012) 1.41
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction (2007) 1.41
Access to and use of health services among undocumented Mexican immigrants in a US urban area. Am J Public Health (2008) 1.41
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend (2008) 1.41
Protection of racial/ethnic minority populations during an influenza pandemic. Am J Public Health (2009) 1.40
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (2012) 1.38
The HCV Synthesis Project: scope, methodology, and preliminary results. BMC Med Res Methodol (2008) 1.34
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health (2008) 1.33
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health (2011) 1.32
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.31
Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women. Am J Public Health (2010) 1.31
Impact of social network characteristics on high-risk sexual behaviors among non-injection drug users. Subst Use Misuse (2007) 1.22
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend (2010) 1.21
Reconsidering the internet as an HIV/STD risk for men who have sex with men. AIDS Behav (2010) 1.21
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.21
Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City. J Urban Health (2004) 1.20
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis (2012) 1.20
Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS One (2012) 1.19
Missed opportunities for HIV testing among high-risk heterosexuals. Sex Transm Dis (2009) 1.19
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res (2007) 1.18
Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. Am J Public Health (2008) 1.18
Relationships between childhood abuse and neglect experience and HIV risk behaviors among methadone treatment drop-outs. Child Abuse Negl (2002) 1.17
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend (2005) 1.17
Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Clin Infect Dis (2011) 1.16
Roundtable on Urban Living Environment Research (RULER). J Urban Health (2011) 1.14
Strategies for improving influenza immunization rates among hard-to-reach populations. J Urban Health (2007) 1.14
A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med (2008) 1.13
A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health (2008) 1.13
Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. Int J Drug Policy (2007) 1.13
Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend (2009) 1.12
Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend (2005) 1.12
Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. J Infect Dis (2006) 1.11
Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry. Drug Alcohol Depend (2002) 1.11
Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J Hepatol (2010) 1.10
Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis (2004) 1.10
Herpes simplex virus-2 and HIV among noninjecting drug users in New York city. Sex Transm Dis (2007) 1.09
Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies. J Am Pharm Assoc (2003) (2010) 1.09
Hepatitis C knowledge among staff in U.S. drug treatment programs. J Drug Educ (2006) 1.08
Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users. Drug Alcohol Depend (2009) 1.07
Recruitment-adjusted estimates of HIV prevalence and risk among men who have sex with men: effects of weighting venue-based sampling data. Public Health Rep (2011) 1.07
Puerto Rican drug users experiences of physical and sexual abuse: comparisons based on sexual identities. J Sex Res (2003) 1.07
Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav (2006) 1.06
Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health (2007) 1.06
Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J Urban Health (2011) 1.05
Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. AIDS Patient Care STDS (2010) 1.05
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend (2007) 1.05
Impact of the September 11th attacks in New York City on drug users: a preliminary assessment. J Urban Health (2002) 1.05
Health care utilization and risk behaviors among HIV positive minority drug users. J Health Care Poor Underserved (2006) 1.05
Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units. AIDS Patient Care STDS (2005) 1.03
Patterns of exchange sex and HIV infection in high-risk heterosexual men and women. J Urban Health (2011) 1.03
Estimated HIV incidence among high-risk heterosexuals in New York City, 2007. J Acquir Immune Defic Syndr (2011) 1.02
HIV transmission behaviors in jail/prison among puerto rican drug injectors in New York and Puerto Rico. AIDS Behav (2005) 1.02
Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clin Infect Dis (2003) 1.02
Methods to measure the impact of home, social, and sexual neighborhoods of urban gay, bisexual, and other men who have sex with men. PLoS One (2013) 1.01
The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health (2004) 1.01
Predicting treatment retention with a brief "Opinions About Methadone" scale. J Psychoactive Drugs (2006) 1.01
Challenges in recruiting and training drug treatment patients as peer outreach workers: a perspective from the field. Subst Use Misuse (2010) 1.00
Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City. AIDS Behav (2006) 1.00
Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamón, Puerto Rico. J Psychoactive Drugs (2003) 1.00